Dental Bone Graft Substitutes Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite

Dental Bone Graft Substitutes Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite


  • Year: 2019
  • Scope: 2015-2025
  • Region: Argentina, Australia, Brazil, China, Europe, India, Japan, Mexico, South Korea, United States
  • Published Date: 01/03/2019
  • Pages: 3577
  • Type: MedSuite

Industry Trends

A major limiter preventing market growth in the dental bone graft substitute and other biomaterials markets is the commoditization across the dental bone graft substitute and dental barrier membrane segments. While various distributors compete for market share, many receive their products from the same suppliers, and further market penetration of small competitors has resulted in less product differentiation and more affordable options. This is applying downward pressure on the ASP, limiting the market value going forward.

The growing number of general practitioners (GPs) placing implants is driving the total markets for dental bone graft substitutes and other biomaterials forward by increasing the volume of dental
implant procedures. The increased number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw prior to the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate dental biomaterials.

One trend within the dental bone graft substitute and other biomaterials markets is the bundling of bone graft materials with large-scale implant purchases, rendering the products extremely discounted or even complimentary. As periodontists and oral surgeons outnumber general practitioners in terms of the number of dentists placing implants in the United States, and as these specialists tend to buy in bulk, this trend is expected to persist in the future.

The European market is seeing a trend in the growth of allograft product use. The continent is experiencing double-digit growth in allograft products, due to their effectiveness. While regulatory barriers have somewhat limited the allograft space, demand is forecasted to drive growth through 2025.

dental bone graft substitutes market value forecast chart from United States report by iData Research

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:

  • United States
  • Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Brazil
  • Mexico
  • Argentina


The Only Medical Device Market Research With:

Procedure Volume Data & Trends
Unit Sales Growth Analysis
Average Selling Prices
Competitor Shares by Segment & Country
 Interview-based Research Methods
 The Lowest Acquisition Cost

Highly Detailed Segmentation

While this report suite contains all applicable market data, each of the market segments are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

  • Market Overview for Dental Bone Graft Substitutes – MedView
  • Procedure Numbers for Dental Bone Graft Substitutes – MedPro
  • Market Report for Dental Bone Graft Substitutes – MedCore
  • Market Report for Dental Growth Factor – MedCore
  • Market Report for Dental Barrier Membranes – MedCore

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Full Segmentation Map for the United States

dental bone graft substitutes market segmentation map by iData Research

Market Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2025, and Historical Data to 2015
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Dental Bone Graft Substitutes Market Share Insights

Geistlich is a clear leader in the dental bone graft substitutes market, particularly in Europe, where they command more than one-third of the market share themselves. The U.S. market sees stronger competition from Zimmer Biomet, ACE Surgical, and BioHorizons to compete as leaders in this space. Geistlich’s emerging market share in the overall market is a direct result of their
dominance strictly within the xenograft market. The Bio-Oss® bovine xenograft product line in the xenograft realm of DBGS is recognized as the gold standard within the xenograft market. In fact, the product is the clear leader of the xenograft market.

Combining the dental divisions of each company, Zimmer Dental and BIOMET 3i merged in June of 2015, creating an entity that rivals that of Geistlich in the United States. The company continues to maintain a strong presence in the overall DBGS market by providing products in the mineralized allograft, DBM allograft, xenograft and synthetic sub-segments of the market. In the European market Zimmer Biomet still trails behind Botiss Biomaterials.

Botiss continues to experience significant growth, largely owing to its distribution deal established with Straumann, a leading dental implant manufacturer. The company is headquartered in Berlin, Germany and has R&D and production sites in Germany, Austria and the United Kingdom. Unlike Geistlich, the leading competitor in the market, Botiss maintains a much more varied
product portfolio in the dental biomaterial market. Though the company is most successful in the xenograft segment, Botiss also produces and distributes allograft and synthetic DBGS materials.

Throughout this series of research, iData studied over 100 companies in this market. For a full list of companies analyzed see the table below.


All Companies Analyzed in this Study

  • AB Dental
  • ACE Surgical
  • Advanced BioTech Products Ltd.
  • Allgens
  • Alpha-Bio Tec
  • Amann Girrbach
  • Anthogyr
  • Arthrex
  • Augma Biomaterials
  • Australia Biotechnologies
  • B&W
  • Baumer
  • BEGO
  • Beijing YHJ Science and Trade Co.
  • Benco
  • BenQ Corporation
  • Bicon
  • BIOBank
  • BioHorizons
  • Biomatlante
  • BioMimetic
  • BiosLight S.A. de C.V.
  • Biotek
  • Bioxen
  • Botiss Biomaterials
  • BTI
  • Cells + Tissuebank Austria
  • Ceramisys
  • Citagenix
  • Collagen Matrix
  • CoorsTek
  • Cortex Dental
  • CowellMedi
  • Criteria
  • Curasan
  • Danaher Corporation
  • Datum Dental
  • Degradable Solutions
  • Dental Wings
  • Dentegris
  • Dentium USA
  • Dentsply Sirona
  • Dyna Dental
  • Equinox
  • Euroteknika
  • Exactech
  • FGM
  • G. Surgiwear
  • GC Corporation
  • Geistlich
  • Genoss
  • Hans Biomed
  • Henry Schein
  • HOYA Technosurgical
  • IFGL Bio Ceramics Limited
  • Impladent LTD
  • Implant Direct
  • InBiomed
  • Inion
  • Intralock
  • JHS
  • Kasios
  • KaVo Kerr
  • Keramat
  • Keystone Dental
  • Laboratorio Celina
  • LifeNet Health
  • Lutipold Pharmaceuticals
  • Lynch Biologics
  • Matcom
  • Medica-Integral
  • Medtronic
  • MegaGen
  • MIS Implants
  • MTF
  • Neobiotech
  • Neodent
  • Neoss
  • Nobel Biocare
  • Noraker
  • NovaBone
  • Odontit
  • Olympus Terumo Biomaterials
  • Oscotec
  • Osseocon
  • Ossix Dental
  • Osstem Implant
  • OST Development
  • Osteogenics
  • Osteohealth
  • OT Medical
  • Patterson
  • Pharmatrix
  • Regentix
  • Resorba
  • Rocky Mountain Tissue Bank
  • S.I.N.
  • Salvin
  • Shanghai Rebone Biomaterials
  • Shanxi OsteoRad
  • Sheng Chi Biotechnology
  • Silvestre Labs
  • Sistema INP
  • Snoasis Medical
  • Straumann
  • Sunmax Biotechnology
  • Sunstar
  • Tecnoss
  • Tianjin Sannie
  • Tirden
  • Tissue Banks
  • TreeOss
  • UNC
  • Unicare BioMedical
  • W. L. Gore
  • Zimmer Biomet

Latest Market Developments

March 2019 – Straumann Group increases ownership stake in Anthogyr to 100%.

September 2018 – Henry Schein acquires Medentis Medical.

September 2018 – LYNCH Biologics purchases GEM21S® from Luitpold Pharmaceuticals Inc.

One of the the most accurate methods of market research in the medical device industry is to analyze the procedure volumes and trends. Through this study on dental bone graft substitutes, iData Research has performed an analysis on the following procedure segments in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10 year range. While the below market segmentation map is representative of the United States, procedure volume data is also provided for the other regions within this complete series.

Procedure Volume Analysis Segments in the United States

dental bone graft substitutes procedure segmentation available in this report by iData Research

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers